INTERACTIVE DATA TEAMS UP WITH PLURIS TO PROVIDE DAILY INDEPENDENT VALUATIONS FOR MUNICIPAL AUCTION RATE SECURITIESThursday, September 17, 2009 @ 11:24AMNew York, September 17, 2009 – Interactive Data Corporation (NYSE: IDC), a leading provider of financial market data, analytics and related solutions, today announced that its Pricing and Reference Data business now offers clients daily valuations for Municipal Auction Rate Securities (ARS) including Student Loan Auction Rate Securities (SLARS), from Pluris Valuation Advisors, LLC, a provider of ...
Stocks Seeing Modest Strength In Mid-Morning Trading - U.S. CommentaryThursday, September 17, 2009 @ 9:30AM(RTTNews) - Following a shaky start, stocks have moved higher and are posting modest gains in mid-morning trading on Thursday as traders were presented with a series of promising economic reports.
Interactive Data Teams up with Pluris to Provide Daily Independent Valuations for Municipal Auction Rate SecuritiesThursday, September 17, 2009 @ 8:00AMNEW YORK----Interactive Data Corporation , a leading provider of financial market data, analytics and related solutions, today announced that its Pricing and Reference Data business now offers clients daily valuations for Municipal Auction Rate Securities including Student Loan Auction Rate Securities , from Pluris Valuation Advisors LLC, a provider of market-based valuations of illiquid ...
Your News Content Is Worth Zero to Digital ConsumersWednesday, September 16, 2009 @ 6:26PMNews publishers expecting to make money from their digital readers will need to figure out how to offer something tangible -- and mobile represents big-time opportunity, especially for phone applications.
Human neural stem cells to treat Pelizaeus-Merzbacher DiseaseThursday, September 10, 2009 @ 8:55AMStemCells, Inc. (NASDAQ:STEM) announced today that it will soon initiate with the University of California, San Francisco (UCSF) Children’s Hospital a Phase I clinical trial to evaluate the therapeutic potential of StemCells’ proprietary HuCNS-SC® product candidate (purified human neural stem cells) to treat Pelizaeus-Merzbacher Disease (PMD), a myelination disorder that primarily affects ...